Position in CRMD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,651,185
-$1,508,569 QoQ
Shares Held
243,179
-10.5% QoQ
Ownership
0.310%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRMD Over Time
Shares Held
Position Value (USD)
Derivatives in CRMD
reported options exposure · as of Dec 31, 2025CallValue
$1,163,000
CallShares
100,000
PutValue
$930,400
PutShares
80,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026LAZARD ASSET MANAGEMENT LLC holds $361,300,548 across 55 Biotechnology names. CRMD ranks #27 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
133,347 | $97,376,646 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
213,131 | $95,171,516 | |
| 3 | INCY |
Incyte Corp
|
219,881 | $20,695,199 | |
| 4 | ONC |
BeOne Medicines Ltd.
|
62,917 | $18,684,461 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
325,851 | $18,407,322 | |
| 6 | EXEL |
Exelixis, Inc.
|
372,600 | $15,980,814 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
17,004 | $13,137,970 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
42,723 | $8,076,783 |
All Filings in CRMD
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,651,185 | 243,179 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,159,754 | 271,690 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $1,163,000 | 100,000 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $930,400 | 80,000 | Put | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||